fixyruw.wordpress.com
Mario joins the privately held drug development compangy from ofNew Jersey, where he was CEO. He has held managemeny positions at SmithKline and Squibbv and joined Glaxoin 1986. He replaces Mark Platshon as CEO. During his time at Glaxo, Mario oversae the launch of five majore brands that grewthe company's sales and profitw by nearly 15 percen t annually, according to Palo Alto-based Capnia. In 1993, he became CEO of which acquiredin 2001.
"Ernie's extensive experiencd in all aspects of the pharmaceutical industry will be invaluablew to Capnia as we prepare to advance our Capellza treatment for migraine and rhinitisinto late-stages clinical studies," said Edgar Engleman, managing partner of , Capnia's lead Also joining Capnia are two other pharmaceuticapl executives who previously worked with Mario. James Butlefr will be senior vice president, marketing, and Ron Haak will be senior vice president, technology development. Besides Vivo Ventures of Palo Capnia backers include ofPalo Alto, TeknoInvest and Alliance Venture, both of Norway, Sagamore Bioventures of San Francisco.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment